Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Perrigo Company plcNYSE: PRGO
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $179.1M rose 107.5% year over year, ahead of the +22.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 115.0% from the prior quarter. Over 3 fiscal years it compounded at -0.1% a year.
Context
- Depreciation & amortization amounted to 7.9% of revenue in FY2025, up 0.5 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +107.5% holds above the trailing-twelve-month pace of +22.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 337.5M USD
- Year-over-year change
- +3.6%
- 4-year CAGR
- +2.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 337.5M | +3.6% |
| FY2024 | 2024-12-31 | 325.9M | -9.3% |
| FY2023 | 2023-12-31 | 359.5M | +6.2% |
| FY2022 | 2022-12-31 | 338.6M | +8.5% |
| FY2021 | 2021-12-31 | 312.2M | — |
Depreciation & Amortization vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 depreciation & amortization of $403.5M is the 2nd largest of the 10 companies compared; the peer median is $64M.
- Its year-over-year change of +22.7% is the 3rd highest of 10, against a peer median of +11.3%.
- Depreciation & amortization amounts to 9.7% of revenue for PRGO, versus a peer median of 5.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.17B | -5.6% | -4.7% | 10.8% | |
| LTM Jun 2026 | $403.5M | +22.7% | -0.1% | 9.7% | |
| LTM Sep 2026 | $177.3M | +18.2% | +15.3% | 5.3% | |
| LTM Jun 2026 | $101.71M | +26.1% | +2.3% | 12.2% | |
| LTM Mar 2026 | $88.73M | +3.7% | +33.7% | 11.3% | |
| LTM Sep 2026 | $64M | +11.3% | -10.1% | 4.2% | |
| LTM Jun 2025 | $12.21M | +14.7% | +15.5% | 2.0% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $9.44M | +9.0% | — | 4.0% |
| LTM Sep 2026 | $2.91M | +66.6% | +77.3% | 0.4% | |
| LTM Sep 2026 | $1.32M | -19.2% | -17.8% | 230.7% | |
| Peer median (excluding PRGO) | $64M | +11.3% | +8.8% | 5.3% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (68.9M) | (130.9M) | (12.7M) | (171.8M) | (1.4B) |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| Deferred Income Tax | 9.4M | (50.5M) | (106.6M) | 9.8M | (50.8M) |
| Stock-Based Compensation | 60.1M | 0 | 68.8M | 64.4M | 0 |
| Change in Working Capital | (295.4M) | 20M | (58.5M) | (74.7M) | (101.1M) |
| Accounts Receivables | (159.7M) | 100K | (57.1M) | (11.1M) | 30.7M |
| Inventory | (2.4M) | (76.7M) | 19.4M | 13.7M | (61.1M) |
| Accounts Payables | (7.9M) | 100.3M | (65.9M) | 54.2M | (28.7M) |
| Other Working Capital | (125.4M) | (3.7M) | 45.1M | (131.5M) | (42M) |
| Other Non-Cash Items | 138.9M | 130.1M | 155M | 209.3M | 1.46B |
| Operating Cash Flow | 156.3M | 307.3M | 405.5M | 362.9M | 238.5M |
| Capital Expenditures | (152.1M) | (96.4M) | (101.7M) | (118.3M) | (93.4M) |
| Acquisitions (Net) | 1.49B | (1.95B) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (64M) | 90.5M | 24.2M | 197.1M | 18M |
| Investing Cash Flow | 1.28B | (1.96B) | (77.5M) | 78.8M | (75.4M) |
| Debt Repayment | (30.6M) | 583.6M | (30.2M) | (437.8M) | (34.8M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (129.6M) | (142.4M) | (149.7M) | (152.5M) | (159.3M) |
| Other Financing Activities | (18.5M) | (19.6M) | (7.3M) | (20.7M) | (26.4M) |
| Financing Cash Flow | (178.7M) | 421.6M | (187.2M) | (611M) | (220.5M) |
| Effect of Forex Changes | (15.6M) | (34.5M) | 9.8M | (23.2M) | 30.2M |
| Net Change in Cash | 1.23B | (1.26B) | 150.6M | (192.5M) | (27.2M) |
| Free Cash Flow | 4.2M | 210.9M | 303.8M | 244.6M | 145.1M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.